A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Vaccine

• Publication date

  2009-09-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2009.07.002PMID 19616493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2011cited by this paper
• Efficacy and Safety of 1 and 2 Doses of Live Attenuated Influenza Vaccine in Vaccine-Naive Children

  2009cited by this paper
• Influenza vaccination coverage among children aged 6-59 months--six immunization information system sentinel sites, United States, 2006-07 influenza season.

  2007cited by this paper
• Live attenuated versus inactivated influenza vaccine in infants and young children.

  2007cited by this paper
• Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in Asia

  2007cited by this paper
• State-specific influenza vaccination coverage among adults aged > or =18 years--United States, 2003-04 and 2005-06 influenza seasons.

  2007cited by this paper
• Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections

  2006cited by this paper
• Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care

  2006cited by this paper
• The underrecognized burden of influenza in young children.

  2006cited by this paper
• General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2006cited by this paper
• Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma

  2006cited by this paper
• Influenza in Tropical Regions

  2006cited by this paper
• H5N1 avian influenza: first steps towards development of a human vaccine.

  2005cited by this paper
• Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries.

  2003cited by this paper
• Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities.

  2003cited by this paper
• Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.

  2002cited by this paper
• General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP).

  2002cited by this paper
• Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.

  2002cited by this paper
• Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults.

  2001cited by this paper
• Recommended composition of influenza virus vaccines for use in the 2001-2002 season.

  2001cited by this paper
• Prevention of otitis media in children with live attenuated influenza vaccine given intranasally.

  2000cited by this paper
• Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

  2000cited by this paper
• Vaccines: World Health Organization versus Federal Drug Administration recommended formula.

  2000cited by this paper
• Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.

  2000cited by this paper
• Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2000cited by this paper
• The global impact of influenza on morbidity and mortality.

  1999cited by this paper
• The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

  1998cited by this paper
• Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases.

  1997cited by this paper
• Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine.

  1995cited by this paper
• A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.

  1994cited by this paper
• Acute respiratory illness in the community. Frequency of illness and the agents involved

  1993cited by this paper
• Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.

  1991cited by this paper
• Report of the Committee on Infectious Diseases

  1989cited by this paper
• Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine

  1988cited by this paper
• Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain.

  1986cited by this paper
• Interpandemic influenza in the Houston area, 1974-76.

  1978cited by this paper
• Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children

  year unknowncited by this paper

• Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain

  2024cites this paper
• Non-linear effects of age in reporting of adverse events following influenza immunization in Zhejiang, China

  2024cites this paper
• Timing and sequence of vaccination against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial

  2023cites this paper
• The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24–59 months in The Gambia: a phase 4, open label, randomised, controlled trial

  2021cites this paper
• Adverse events following influenza immunization: understanding the role of age and sex interactions

  2021cites this paper
• Safety of Co-Administration Versus Separate Administration of the Same Vaccines in Children: A Systematic Literature Review

  2019cites this paper
• Role of innate lymphoid cells and dendritic cells in intradermal immunization of the enterovirus antigen

  2019cites this paper
• Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis.

  2018cites this paper
• Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season

  2017cites this paper
• Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2017–18 Influenza Season

  2017cites this paper
• Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial

  2016cites this paper
• Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season

  2015cites this paper
• The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.

  2015cites this paper
• Vaccination of children with a live-attenuated, intranasal influenza vaccine – analysis and evaluation through a Health Technology Assessment

  2014cites this paper
• Quadrivalent Ann Arbor strain live-attenuated influenza vaccine

  2012cites this paper
• The role of nasal IgA in children vaccinated with live attenuated influenza vaccine.

  2012cites this paper
• national advisory Committee on immunization ( naCi ) Statement on SeaSonal Influenza VaccIne for 2012-2013 Appendix I : New Evidence Review for Children 24 to 59 Months of Age Preamble

  2012cites this paper
• STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

  2012cites this paper
• Statement on Seasonal Influenza Vaccine for 2012-2013: Appendix I: New Evidence Review for Children 24 to 59 Months of Age: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

  2012cites this paper
• Live Attenuated Influenza Vaccine (Fluenz™)

  2012cites this paper
• Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study *

  2012cites this paper
• Live Attenuated Influenza Vaccine (FluMist®; Fluenz™)

  2011cites this paper
• An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2–17 years

  2011cites this paper
• randomized , double-blind noninferiority study of quadrivalent live attenuated nfluenza vaccine in adults

  2011cites this paper
• A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.

  2011cites this paper
• Live attenuated influenza vaccine--a review.

  2011cites this paper
• Recommendations on the use of live, attenuated influenza vaccine (FluMist®): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†.

  2011cites this paper
• Epidemiology of Influenza in Tropical and Subtropical Low-Income Regions

  2011cites this paper
• Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.

  2010cites this paper
• Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials

  2010cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2010cites this paper
• Safety and Immunogenicity Following Administration of a Live , Attenuated Monovalent 2009 H 1 N 1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials

  2010cites this paper
• Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines

  2009cites this paper
• An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)

  2007cites this paper